skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Since the discovery of the microbiome, biomedical research has been highly focused on understanding how exactly its interactions within the body contribute to health and disease, and drug development companies are very interested in understanding the potential of microbiome modulating therapies.


The topics covered include:

  • Major therapeutic areas of drug development including infectious disease, gastrointestinal disorders, metabolic diseases, dermatological conditions, and early research in cancers and neurological indications
  • The time trend in microbiome drug development
  • The current development landscape, including number of microbiome modulators at each development phase
  • The top companies investing the most in this research area, and microbiome research collaborations

Next steps



  • 日本:         +81 3 6273 4260
  • 米国 (無料):+1 888 670 8900
  • 米国 (有料):+1 908 547 2200
  • 英国&欧州:+44 (20) 337 73737
  • 豪:      +61 2 8705 6907